Weiming Mou

966 total citations · 1 hit paper
30 papers, 235 citations indexed

About

Weiming Mou is a scholar working on Oncology, Health Informatics and Molecular Biology. According to data from OpenAlex, Weiming Mou has authored 30 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Health Informatics and 9 papers in Molecular Biology. Recurrent topics in Weiming Mou's work include Artificial Intelligence in Healthcare and Education (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Gut microbiota and health (5 papers). Weiming Mou is often cited by papers focused on Artificial Intelligence in Healthcare and Education (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Gut microbiota and health (5 papers). Weiming Mou collaborates with scholars based in China, Hong Kong and United States. Weiming Mou's co-authors include Lingxuan Zhu, Peng Luo, Anqi Lin, Jian Zhang, Aimin Jiang, Zaoqu Liu, Quan Cheng, Haijun Yu, Cheng Quan and Yancheng Lai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Weiming Mou

29 papers receiving 229 citations

Hit Papers

From chaos to order: optimizing fecal microbiota transpla... 2025 2026 2025 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiming Mou China 11 70 64 39 35 32 30 235
Zhihang Chen China 5 51 0.7× 42 0.7× 41 1.1× 21 0.6× 47 1.5× 8 211
Xuehang Jin China 6 39 0.6× 99 1.5× 55 1.4× 32 0.9× 13 0.4× 10 244
Rahul K. Arora Canada 8 41 0.6× 103 1.6× 13 0.3× 28 0.8× 32 1.0× 27 258
Najib Ben Khaled Germany 9 68 1.0× 30 0.5× 19 0.5× 48 1.4× 16 0.5× 40 258
Elisabetta Xue Italy 9 63 0.9× 26 0.4× 33 0.8× 8 0.2× 32 1.0× 31 228
Aditi Gnanasekar United States 4 99 1.4× 128 2.0× 16 0.4× 32 0.9× 12 0.4× 6 303
Kerstin Pfister Germany 6 15 0.2× 31 0.5× 67 1.7× 17 0.5× 37 1.2× 22 240
Erica K. Barnell United States 10 108 1.5× 107 1.7× 7 0.2× 43 1.2× 21 0.7× 25 296
Amy Livesey United Kingdom 4 20 0.3× 50 0.8× 19 0.5× 29 0.8× 152 4.8× 5 268
Oriana Strianese Italy 6 27 0.4× 64 1.0× 6 0.2× 82 2.3× 15 0.5× 14 222

Countries citing papers authored by Weiming Mou

Since Specialization
Citations

This map shows the geographic impact of Weiming Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiming Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiming Mou more than expected).

Fields of papers citing papers by Weiming Mou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiming Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiming Mou. The network helps show where Weiming Mou may publish in the future.

Co-authorship network of co-authors of Weiming Mou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiming Mou. A scholar is included among the top collaborators of Weiming Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiming Mou. Weiming Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Anqi, Aimin Jiang, Li Chen, et al.. (2025). Large language models in clinical trials: applications, technical advances, and future directions. BMC Medicine. 23(1). 563–563. 1 indexed citations
2.
Jiang, Aimin, Weiming Mou, Dongqiang Zeng, et al.. (2025). Temporal evolution of large language models (LLMs) in oncology. Journal of Translational Medicine. 23(1). 1219–1219.
3.
Gao, Zhifei, Aimin Jiang, Zizhuo Li, et al.. (2025). Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development. SHILAP Revista de lepidopterología. 1(1). 32–61. 10 indexed citations
4.
Jiang, Tong, Aimin Jiang, Qi Chang, et al.. (2025). Performance analysis of large language models in multi-disease detection from chest computed tomography reports: a comparative study. International Journal of Surgery. 111(8). 5071–5087. 1 indexed citations
5.
Huang, Li‐Hua, Cangang Zhang, Aimin Jiang, et al.. (2025). T-cell Senescence in the Tumor Microenvironment. Cancer Immunology Research. 13(5). 618–632. 7 indexed citations
6.
Zhang, Pengpeng, Cangang Zhang, Aimin Jiang, et al.. (2025). The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy. EBioMedicine. 115. 105708–105708. 14 indexed citations
7.
Yu, Haijun, Chunyan Zhang, Aimin Jiang, et al.. (2025). Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors. npj Biofilms and Microbiomes. 11(1). 180–180. 4 indexed citations
8.
She, Guorong, Anqi Lin, Weiming Mou, et al.. (2025). ChatGPT’s role in alleviating anxiety in total knee arthroplasty consent process: a randomized controlled trial pilot study. International Journal of Surgery. 111(3). 2546–2557. 5 indexed citations
9.
Lin, Anqi, Aimin Jiang, Lingxuan Zhu, et al.. (2025). Circadian rhythms as a modulator of gut microbiota-tumor microenvironment crosstalk. Cellular and Molecular Life Sciences. 82(1). 409–409. 1 indexed citations
10.
Lin, Anqi, Aimin Jiang, Lingxuan Zhu, et al.. (2025). Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors. BMC Medicine. 23(1). 341–341. 10 indexed citations
11.
Zhu, Lingxuan, Weiming Mou, Yancheng Lai, et al.. (2024). The Evaluation of Generative AI Should Include Repetition to Assess Stability. JMIR mhealth and uhealth. 12. e57978–e57978. 10 indexed citations
12.
Zhu, Lingxuan, Weiming Mou, Yancheng Lai, et al.. (2024). Multimodal ChatGPT-4V for Electrocardiogram Interpretation: Promise and Limitations. Journal of Medical Internet Research. 26. e54607–e54607. 13 indexed citations
13.
Jiang, Aimin, Zhengang Qiu, Anqi Lin, et al.. (2024). Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications. Frontiers of Medicine. 18(6). 945–968. 6 indexed citations
14.
Zhu, Lingxuan, et al.. (2024). Can DALL-E 3 Reliably Generate 12-Lead ECGs and Teaching Illustrations?. Cureus. 16(1). e52748–e52748. 12 indexed citations
15.
Cheng, Xiangshu, Aimin Jiang, Wenjie Shi, et al.. (2024). Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment. Advanced Science. 11(47). e2403423–e2403423. 12 indexed citations
16.
Lin, Anqi, Haitao Wang, Lingxuan Zhu, et al.. (2024). Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies. Journal of Global Health. 14. 4067–4067. 14 indexed citations
17.
Lin, Anqi, Weiming Mou, Lingxuan Zhu, et al.. (2023). Mutations in the DNA polymerase binding pathway affect the immune microenvironment of patients with small‐cell lung cancer and enhance the efficacy of platinum‐based chemotherapy. SHILAP Revista de lepidopterología. 2(6). 500–512. 1 indexed citations
18.
Liu, Jiaying, Yidong Chen, Anqi Lin, et al.. (2022). Application of ATAC-seq in tumor-specific T cell exhaustion. Cancer Gene Therapy. 30(1). 1–10. 11 indexed citations
19.
Mou, Weiming, Lingxuan Zhu, Tao Yang, et al.. (2022). Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status. Cancer Cell International. 22(1). 229–229. 3 indexed citations
20.
Zhou, Chaozheng, Anqi Lin, Weimin Ding, et al.. (2021). Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma. Frontiers in Immunology. 12. 634741–634741. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026